Clinical Trial Update: Circulating Tumor DNA Alterations in Non-small Cell Lung Cancer Patients Treated With Pembrolizumab

View source ↗

Summary

Clinical trial update indicates the study examining circulating tumor DNA alterations in non-small cell lung cancer patients treated with pembrolizumab has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Columbia University | Conditions: Non Small Cell Lung Cancer | Status: TERMINATED